Accessibility statement

Will drug prices rise following a UK-US trade deal?

Posted on 12 November 2019

Karl Claxton writes for The Conversation

The Conversation Logo

Michael Gove’s denials that the NHS or UK drug prices will be part of any negotiation lacks credibility, given the recent and clearly stated US policy objectives (which are to ensure other countries pay higher prices for US drugs in future trade deals), the fact the US has included drug prices in other trade deals with Canada, Mexico and South Korea and that a former trade negotiator for US president Donald Trump said that he doesn’t understand what the UK’s prime minister meant when he said that the NHS was not on the table earlier this year. Read more